Published May 28, 2007

Robin Hanson on Health

Russ Roberts and Robin Hanson delve into the paradoxes of healthcare, questioning its effectiveness and economic efficiency by examining biases, signaling, and historical insights, ultimately suggesting that much healthcare spending may be driven by social motivations rather than genuine health improvements.
Episode Highlights
EconTalk logo

Popular Clips

Episode Highlights

  • Rand Experiment

    The Rand Health Experiment offers surprising insights into the relationship between healthcare spending and health outcomes. explains that despite increased access to free medicine, the experiment showed no significant improvement in health compared to those who paid for their care 1. This challenges the assumption that more healthcare spending directly correlates with better health. highlights the experiment's importance, noting that many remain unaware of its findings 2.

    The Rand experiment was an attempt to do it right. We're not just going to look at correlations. We're going to do the randomized experiment just like you do with a standard clinical trial.

    ---

    The study's results suggest that the marginal benefit of additional healthcare is often negligible, raising questions about the efficiency of current healthcare spending 3.

       

    Spending Inefficiencies

    Healthcare spending inefficiencies are highlighted through economic incentives that often misalign with patient benefits. argues that the common belief of "you get what you pay for" doesn't hold true in healthcare, as increased spending doesn't always equate to better outcomes 4. points out that unlike other sectors, healthcare and education tolerate inefficient systems due to a lack of consumer awareness and economic understanding 5.

    Medicine and education are distinct from other areas of life. One of the symptoms of that difference is the fact that people tolerate crappy institutions that produce crappy incentives.

    ---

    Additionally, pharmaceutical spending, while significant, represents only a small fraction of total healthcare costs, suggesting that focusing solely on drug prices may not address broader inefficiencies 6.

Related Episodes